The DOI matches its Crossref record; 209 of the 209 references it cites were found in a registry or an index.
Injection allergen immunotherapy for asthma
Open accessAbstract
BACKGROUND: Allergen specific immunotherapy has long been a controversial treatment for asthma. Although beneficial effects upon clinically relevant outcomes have been demonstrated in randomised controlled trials, there remains a risk of severe and sometimes fatal anaphylaxis. The recommendations of professional bodies have ranged from cautious acceptance to outright dismissal. With increasing interest in new allergen preparations and methods of delivery, we updated the systematic review of allergen specific immunotherapy for asthma. OBJECTIVES: The objective of this review was to assess the effects of allergen specific immunotherapy for asthma. SEARCH STRATEGY: We searched the Cochrane Airways Group Trials Register up to 2005, Dissertation Abstracts and Current Contents. SELECTION CRITERIA: Randomised controlled trials using various forms of allergen specific immunotherapy to treat asthma and reporting at least one clinical outcome. DATA COLLECTION AND ANALYSIS: Three authors independently assessed eligibility of studies for inclusion. Two authors independently performed quality assessment of studies. MAIN RESULTS: Eighty-eight trials were included (13 new trials). There were 42 trials of immunotherapy for house mite allergy; 27 pollen allergy trials; 10 animal dander allergy trials; two Cladosporium mould allergy, two latex and six trials looking at multiple allergens. Concealment of allocation was assessed as clearly adequate in only 16 of these trials. Significant heterogeneity was present in a number of comparisons. Overall, there was a significant reduction in asthma symptoms and medication, and improvement in bronchial hyper-reactivity following immunotherapy. There was a significant improvement in asthma symptom scores (standardised mean difference -0.59, 95% confidence interval -0.83 to -0.35) and it would have been necessary to treat three patients (95% CI 3 to 5) with immunotherapy to avoid one deterioration in asthma symptoms. Overall it would have been necessary to treat four patients (95% CI 3 to 6) with immunotherapy to avoid one requiring increased medication. Allergen immunotherapy significantly reduced allergen specific bronchial hyper-reactivity, with some reduction in non-specific bronchial hyper-reactivity as well. There was no consistent effect on lung function. If 16 patients were treated with immunotherapy, one would be expected to develop a local adverse reaction. If nine patients were treated with immunotherapy, one would be expected to develop a systemic reaction (of any severity). AUTHORS' CONCLUSIONS: Immunotherapy reduces asthma symptoms and use of asthma medications and improves bronchial hyper-reactivity. One trial found that the size of the benefit is possibly comparable to inhaled steroids. The possibility of local or systemic adverse effects (such as anaphylaxis) must be considered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–209 of 209
Enhanced IL-10 secretion by PBMC during the ragweed season: Effect of AIC immunotherapy vs placebo
Creticos, P. S., Lighvani, S., Bieneman, A. P., Balcer-Whaley, S. L., Norman, P. S., Lichtenstein, L. M., & Schroeder, J. T. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(03)80689-9 · Cited by 7
Hyposensitizing (Immunizing) Inoculations in Hay Fever and Asthma
Levin, S. J. (1959) · Pediatric Clinics of North America · doi:10.1016/s0031-3955(16)30827-6 · Cited by 6
VILLALMANZO, I. G., Hernandez, M. D., Campos, A., Giner, A. M., Polo, F., Cortés, C., & Basomba, A. (1999) · PubMed · Cited by 5
Haahtela, T., Wihl, J. ‐., Munch, E. P., Vilkka, V., Hagelund, C.-H., & Watson, H. K. (1984) · PubMed · Cited by 5
Goor, W. T. V., & Wüthrich, B. (1971) · PubMed · Cited by 5
IMMUNOTHERAPY WITH POLLENS AND FUNGI
Cleveland, C. H., & Metzger, W. J. (1992) · Immunology and Allergy Clinics of North America · doi:10.1016/s0889-8561(22)00090-x · Cited by 5
[Immunotherapy, clinical and bronchial response].
Muñoz, M. F. M. (1996) · PubMed · Cited by 4
Walker, S. M., Jacobson, M. R., & Durham, S. R. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(03)80958-2 · Cited by 3
Osváth, P., & Endre, L. (1976) · PubMed · Cited by 1
Cited by
Allergen immunotherapy: A practice parameter third update
Cox, L., Nelson, H., Lockey, R., Calabria, C., Chacko, T., Finegold, I., Nelson, M., Weber, R., Bernstein, D. I., Blessing-Moore, J., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.09.034 · Cited by 1,256
Clinical Practice Guideline: Allergic Rhinitis
Seidman, M. D., Gurgel, R. K., Lin, S. Y., Schwartz, S. R., Baroody, F. M., Bonner, J. R., Dawson, D. E., Dykewicz, M. S., Hackell, J. M., Han, J. K., et al. (2015) · Otolaryngology–Head and Neck Surgery · doi:10.1177/0194599814561600 · Cited by 671
Holgate, S. T., Wenzel, S., Postma, D. S., Weiss, S. T., Renz, H., & Sly, P. D. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.25 · Cited by 652
Porsbjerg, C., Melén, E., Lehtimäki, L., & Shaw, D. (2023) · The Lancet · doi:10.1016/s0140-6736(22)02125-0 · Cited by 575
International consensus on allergy immunotherapy
Jutel, M., Agache, I., Bonini, S., Burks, A. W., Calderon, M., Canonica, W., Cox, L., Demoly, P., Frew, A. J., O'Hehir, R., et al. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.04.047 · Cited by 545
Metadata
- Authors
- Abramson, M. J., Puy, R. M., & Weiner, J. M.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2010-08-04
- Volume
- 2010
- Issue
- 8
- Pages
- CD001186-CD001186
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W2160195064
- Cited by
- 497
- References
- 209
- FWCI
- 23.28
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.